Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. 1980

W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald

Influenza infection in renal transplant recipients may cause either morbidity and mortality or acute allograft rejection; thus, routine annual influenza vaccination should be considered. We have studied the humoral and cellular immune responses to influenza virus antigens before and after trivalent vaccine administration in 13 patients and 16 control subjects. The patients, nine of whom were either on alternate-day or low-dose daily steroid therapy, showed highly significant serum hemagglutination-inhibition antibody responses to each influenza virus strain, There was no significant change in mean lymphocyte stimulation index to any influenza virus strain after vaccination in either group. There was no correlation in the patient group between hemagglutination-inhibition antibody titer or response, or lymphocyte stimulation index or response, and the degree of allograft function or dose or duration of immunosuppressive therapy. The vigorous antibody response and the evidence of cellular immunity support the efficacy of influenza vaccination in these patients.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
October 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
June 2021, Transplant infectious disease : an official journal of the Transplantation Society,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
November 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
January 2022, Liver international : official journal of the International Association for the Study of the Liver,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
January 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
May 2019, Transplantation proceedings,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
April 2006, Journal of virology,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
June 2000, Transplantation,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
September 2014, Transplant international : official journal of the European Society for Organ Transplantation,
W A Briggs, and R J Rozek, and S D Migdal, and J L Shillis, and R G Brackett, and F B Brandon, and S K Mahajan, and F D McDonald
January 2015, Human vaccines & immunotherapeutics,
Copied contents to your clipboard!